Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shaughnessy

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
The American Journal of Cardiology|September 25, 1999
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertensionA Rothman, M S Sklansky, V W Lucas, et al.
Blood|October 16, 2007
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsUnn-Merete Fagerli, Randi U Holt, Toril Holien, et al.
Blood|December 8, 2009
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcomeJames J Driscoll, Dheeraj Pelluru, Konstantinos Lefkimmiatis, et al.
Blood Cancer Journal|March 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patientsHira Cheema, Asis Shrestha, Syed Naqvi, et al.
British Journal of Haematology|May 11, 2007
Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular geneticsJohn D Shaughnessy, Jeffrey Haessler, Frits van Rhee, et al.
Leukemia|February 3, 2015
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myelomaR Khan, S Apewokin, M Grazziutti, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2Yiming Zhou, Lijuan Chen, Bart Barlogie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profilingJeffrey Haessler, John D Shaughnessy, Fenghuang Zhan, et al.
Blood Advances|July 1, 2025
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imagingCarolina Schinke, Leo Rasche, Cody Ashby, et al.
Clinical Hematology International|September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaTanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
The American Journal of Cardiology|September 25, 1999
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertensionA Rothman, M S Sklansky, V W Lucas, et al.
Blood|October 16, 2007
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsUnn-Merete Fagerli, Randi U Holt, Toril Holien, et al.
Blood|December 8, 2009
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcomeJames J Driscoll, Dheeraj Pelluru, Konstantinos Lefkimmiatis, et al.
Blood Cancer Journal|March 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patientsHira Cheema, Asis Shrestha, Syed Naqvi, et al.
British Journal of Haematology|May 11, 2007
Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular geneticsJohn D Shaughnessy, Jeffrey Haessler, Frits van Rhee, et al.
Leukemia|February 3, 2015
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myelomaR Khan, S Apewokin, M Grazziutti, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2Yiming Zhou, Lijuan Chen, Bart Barlogie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profilingJeffrey Haessler, John D Shaughnessy, Fenghuang Zhan, et al.
Blood Advances|July 1, 2025
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imagingCarolina Schinke, Leo Rasche, Cody Ashby, et al.
Clinical Hematology International|September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaTanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Pageof 20